Kuopio, Finland

Tuomas Oravilahti

This inventor holds 1 USPTO granted patent. Top assignee: Flx Discoveries Oy. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tuomas Oravilahti. Retrieved from https://idiyas.com/inventor/tuomas-oravilahti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tuomas Oravilahti: Innovator in Androgen Receptor Modulation

Introduction

Tuomas Oravilahti is a notable inventor based in Kuopio, Finland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of non-steroidal compounds that act as androgen receptor modulators. His work is essential for advancing therapeutic options in hormone-related conditions.

Latest Patents

Oravilahti holds a patent for "Non-steroidal compounds as androgen receptor modulators." This invention pertains to novel 4,5-dihydroisoxazoles and 4,5-dihydro[1,2,4]-oxadiazoles, which are utilized as androgenic or antiandrogenic agents. The patent outlines methods for their preparation and potential applications in medical treatments.

Career Highlights

Tuomas Oravilahti is associated with Flx Discoveries Oy, where he continues to innovate in the field of drug development. His expertise in creating compounds that modulate androgen receptors positions him as a key player in the pharmaceutical industry.

Collaborations

Oravilahti collaborates with esteemed colleagues, including Jorma Palvimo and Mikael Perakyla. Their combined efforts contribute to the advancement of research and development in their field.

Conclusion

Tuomas Oravilahti's work in developing androgen receptor modulators showcases his innovative spirit and dedication to improving medical therapies. His contributions are vital for future advancements in the treatment of hormone-related disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…